
    
      This is a 1-year open-label (all people involved know the identity of the assigned drug),
      multicenter, single arm, prospective, observational study to explore under natural setting
      the efficacy of drug treatment in children and adolescents diagnosed with ADHD by K-SADS-PL
      (K-SADS-PL is a tool used for ADHD diagnosis. Patient may be diagnosed with ADHD by using
      K-SADS-PL to check if he or she meets the criteria according to Diagnostic and Statistical
      Manual of Mental Disorders & edition (DSM-IV). After obtaining informed consent, investigator
      will prescribe stimulant or non-stimulant ADHD treatment medications (ie, Immediate release
      [IR]/extended release [ER]/osmotic release oral system (OROS) methylphenidate, atomoxetine).
      Efficacy and safety assessments will be performed at 4, 12, 24, 36, and 52 weeks after the
      first day of giving study drug. Progression of symptom improvement and adherence will be
      investigated and associated variables (ie, demographic, clinical, familial and treatment
      factors) will be analyzed.
    
  